PharmaShots | Incisive News in 3 Shots

Subscribe Now

Resubmits

Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg)

Novo Nordisk Resubmits Label Expansion Application to the US FDA for Semaglutide (2.0mg)

May 31, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us